The rational application of liquid biopsy based on next-generation sequencing in advanced non-small cell lung cancer.

Chenglong ZhaoJianghua LiYong-Chang ZhangRui HanYubo WangLi LiYimin ZhangMengxiao ZhuJie ZhengHaiwei DuChen HuCheng-Zhi ZhouNong YangShangli CaiYong He

Published in: Cancer medicine (2022)

CEA combined with CYFRA21-1 could effectively predict the concordance between plasma and tissue biopsies, which could be used for evaluating the priority of plasma and tissue biopsies for gene testing to timely guide clinical applications in advanced lung adenocarcinoma patients.

Keyphrases

advanced non small cell lung cancer
end stage renal disease
ultrasound guided
copy number
epidermal growth factor receptor
chronic kidney disease
newly diagnosed
ejection fraction
peritoneal dialysis
prognostic factors
dna methylation
transcription factor
tyrosine kinase